The Department of Pharmaceuticals told the panel that to assess the regulatory compliance of drug manufacturing premises in the country, the CDSCO along with State Drugs Controllers have conducted risk-based inspections of more than 400 premises.
Poor Quality Drugs In Govt Channels, Only 5.9% Spurious Drug Cases Resolved: Standing Committee
